Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys

NeuroImage

Volumn 14, Issue 5, 2001, Pages 1159-1167

  Zhang, Zhiming ^a   Andersen, Anders ^a   Grondin, Richard ^a   Barber, Tracy ^a   Avison, Robin ^a   Gerhardt, Greg ^a   Gash, Don ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Amphetamine; Apomorphine; Caudate nucleus; Globus pallidus externa; Globus pallidus interna; MRI; Putamen; Rhesus monkey; Substantia nigra

Indexed keywords

APOMORPHINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT;

ADOLESCENT; AGED; AGING; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BODY MOVEMENT; BRAIN MAPPING; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; FEMALE; GLOBUS PALLIDUS; GLOBUS PALLIDUS EXTERNA; LOCOMOTION; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PUTAMEN; RHESUS MONKEY; STIMULUS RESPONSE; SUBSTANTIA NIGRA; WAKEFULNESS;

EID: 0035172714     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1006/nimg.2001.0902     Document Type: Article

References (49)

1. The activity of pars compacta neurons of the monkey substantia nigra is depressed by apomorphine
2. Inhibition of nigral dopamine neurons by systemic and local apomorphine: Possible contribution of dendritic autoreceptors
3. Data analysis for multi-echo acquisition in fMRI
4. Principal component analysis for generalized linear filtering in fMRI
5. The empirical influence function and principal component analysis of the transient fMRI response
6. Age-associated changes in rhesus CNS composition identified by MRI
7. Principal component analysis of the dynamic response measured by fMRI: A generalized linear systems framework
8. Multivariate analysis of pharmacologically-induced changes in MRI responses in alert rhesus monkeys
9. Prevalence of parkinsonian signs and associated mortality in a community population of older people
10. Dynamic mapping of the human visual cortex by high-speed magnetic resonance imaging
11. 3H]Spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
12. 2* by multiple gradient recalled echo functional MRI
13. Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys
14. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data
15. Cerebral T2-weighted signal decrease during aging in the mouse lemur primate reflects iron accumulation
16. Functional magnetic resonance imaging in the macaque cortex
17. Age-related declines in nigral neuronal function correlate with motor impairmentsq in rhesus monkeys
18. Aging and Parkinson's disease: Substantia nigra regional selectivity
19. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism
20. Age differences and changes in reaction time: The baltimore longitudinal study of aging
21. Iron in the basal ganglia in Parkinson's disease: An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy
22. What is a "low dose" of D-amphetamine for inducing behavioral effects in laboratory rats?
23. Effects of apomorphine on globus pallidus neurons in parkinsonian patients
24. Comparison of eight clinical rating scales used for the assessment of MPTP-induced Parkinsonism in the macaque monkey
25. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease
26. Parkinson's disease
27. Pharmacological magnetic resonance imaging: A new application for functional MRI
28. Functional imaging of the monkey brain
29. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine
30. Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra
31. Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging
32. 2 receptor binding with age in rhesus monkeys: Importance of correction for differences in striatal size
33. Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET
34. Basal ganglia pathophysiology: A critical review
35. Pathophysiology of the basal ganglia in Parkinson's disease
36. Brain magnetic resonance imaging with contrast dependent on blood oxygenation
37. Intrinsic signal changes accompanying sensory stimulation: Functional brain mapping with magnetic resonance imaging
38. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
39. Organization of the basal ganglia: The importance of axonal collateralization
40. Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
41. The effect of aging on pars compacta of the substantia nigra in rhesus monkey
42. Developing a stable bilateral model of parkinsonism in rhesus monkeys
43. Anatomy of the dopamine system in the basal ganglia
44. fMRI of monkey visual cortex
45. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals
46. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism
47. Pre- and postsynaptic aspects of dopamine-mediated transmission
48. Motor slowing and parkinsonian signs of aging: Rhesus monkeys mirror human aging
49. Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys